Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Video interview with Devi Nair, MD, who explains how to go fluoroless in PFA procedures. #HRS #HRS24 #HRS2024 #0Fluoro #zerofluoro #EPeeps

How to perform fluoroscopy-free PFA ablation procedures 

Pulsed field ablation is a hot new technology in electrophysiology, but its use of fluoroscopy is associated with certain challenges.

Cardiologist heart

Cardiology salaries are No. 7 among all specialties—thoracic and vascular surgery also make top 10

Physician compensation in the United States is up 6% compared to the previous year, according to a new report. It only increased by 3.9% in cardiology, however, suggesting the specialty is slightly behind the curve.

PSMA PET/CT shows promise for spotting metastatic disease in patients with renal cell carcinoma

Up to 30% of patients have metastatic disease by the time they are initially diagnosed with renal cell carcinoma, making accurate staging a critical element of treatment planning. 

The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”

FDA announces new Class I recall of CPET devices due to choking hazard

If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations. 

Newsweek ranked the 50 best heart hospitals in the world

New York Valves, CRF’s newest cardiology conference, makes heart team collaborations a priority

New York Valves: The Structural Heart Summit replaces the Transcatheter Valve Therapy conference CRF hosted for many years. The three-day event will include 12 late-breaking clinical trials focused on TAVR and new treatments for the mitral and tricuspid valves. 

Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

Thumbnail

Interval breast cancer has its own risk factors, mortality patterns

Women with dense breast tissue are less likely than normal-density peers to develop breast cancer between screening mammography exams.

doctor examines patient data on their tablet

AVR for moderate AS: New 10-year data highlight clear benefits of TAVR, surgery

New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone. 

Displaying 537 - 544 of 5932
Design by Adaptive Theme